Tech Company Financing Transactions

Alydia Health Funding Round

On 9/21/2018, Alydia Health raised $10 million in Series B funding from Global Health Investment Fund, Astia Angel and private investors.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B

Global Health Investment Fund (Lead Investor) (Curt LaBelle)

Astia Angel (Sharon Vosmek)

Proceeds Purpose
The Series B financing will support a U.S. pivotal study of the company's innovative technology designed to prevent the maternal morbidity and mortality caused by postpartum hemorrhage.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
3495 Edison Way
Menlo Park, CA 94025
Email Address
Not Recorded
In 2010, two biomedical engineering students at Cal Poly decided to enter a competition to design an improved PPH treatment. They set a goal of encouraging natural physiologic recovery, creating a device that was designed to work with the natural contraction of the uterus to rapidly stop bleeding. And so, vacuum-induced uterine tamponade was born.
Alydia Health LinkedIn Company Profile
Social Media
Alydia Health Company Twitter Account
Company News
Alydia Health News
Alydia Health on Facebook
Alydia Health on YouTube

Management Team

Email & Social
Chief Executive Officer
Robert Binney
  Robert Binney LinkedIn Profile  Robert Binney Twitter Account  Robert Binney News  Robert Binney on Facebook
Chief Operating Officer
Colby Holtshouse
  Colby Holtshouse LinkedIn Profile  Colby Holtshouse Twitter Account  Colby Holtshouse News  Colby Holtshouse on Facebook
VP - Marketing
Claudia Orellana
  Claudia Orellana LinkedIn Profile  Claudia Orellana Twitter Account  Claudia Orellana News  Claudia Orellana on Facebook
VP - Operations
Steve Lopez
  Steve Lopez LinkedIn Profile  Steve Lopez Twitter Account  Steve Lopez News  Steve Lopez on Facebook
VP - Operations
Kathryn Wine
  Kathryn Wine LinkedIn Profile  Kathryn Wine Twitter Account  Kathryn Wine News  Kathryn Wine on Facebook
VP - R & D
Vaishali Suraj
  Vaishali Suraj LinkedIn Profile  Vaishali Suraj Twitter Account  Vaishali Suraj News  Vaishali Suraj on Facebook
VP - R & D
Andrew Uchida
  Andrew Uchida LinkedIn Profile  Andrew Uchida Twitter Account  Andrew Uchida News  Andrew Uchida on Facebook
VP - Regulatory Affairs
Cindy Domecus
  Cindy Domecus LinkedIn Profile  Cindy Domecus Twitter Account  Cindy Domecus News  Cindy Domecus on Facebook



Browse more venture capital transactions:

Prev: 9/20/2018: Empower venture capital transaction
Next: 9/21/2018: Element Science venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary